159 filings
Page 2 of 8
8-K
j3fvb96
15 May 24
Entry into a Material Definitive Agreement
9:23am
8-K
hwdkdzk0ruv66
15 May 24
Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2024
7:00am
424B3
6efuiku
7 May 24
Prospectus supplement
6:29pm
EFFECT
aqfffy zo84ir5ko5yij
30 Apr 24
Notice of effectiveness
12:15am
8-K
pis34c
26 Apr 24
Allotment and issue of the Second Tranche Placing Shares
7:43am
8-K
1mn30a
23 Apr 24
Entry into a Material Definitive Agreement
5:00pm
8-K
c84zqaz
10 Apr 24
Unregistered Sales of Equity Securities
4:01pm
8-K
b27ug6 lalojn0hp7f4
9 Apr 24
Entry into a Material Definitive Agreement
4:51pm
424B5
f40va24wd hakz
9 Apr 24
Prospectus supplement for primary offering
4:31pm
8-K
ezl3y5gll rq
8 Apr 24
Regulation FD Disclosure
7:44am
8-K
ie28mrz1
29 Mar 24
Entry into a Material Definitive Agreement
4:00pm
8-K
q80o3rark7dy8fvh
14 Mar 24
Guidelines highlight the importance of risk prediction and personalized treatment to reduce risk
7:15am
8-K
fi12bsa2gn4 xvlwwp
13 Mar 24
Entry into a Material Definitive Agreement
7:00am
8-K
xsm0o r3epbg7jtpa0w
4 Mar 24
Regulation FD Disclosure
6:37am
8-K
65csex 7v
29 Feb 24
Regulation FD Disclosure
6:05am
8-K
rhw7kurr
15 Feb 24
Renalytix Reports Financial Results for Second Quarter of Fiscal Year 2024
7:00am